Charles River Laboratories InternationalCRL
紐約證券 · USD
152.66
-16.25
(-9.62%)
收盤 03/13 03:59 (UTC+8)
盤後
151.99
151.99
(-0.44%)
03/13 03:59 (UTC+8)
Charles River Laboratories InternationalCRL
152.66
-16.25
(-9.62%)
財務數據
損益表
- 10.27
- 10.13
- 10.12
- 10.26
- 10.10
- 10.03
- 9.84
- 10.32
- 10.05
- 9.94
- -3.14
- -1.28
- -0.19
- 1.44
- -1.59
- -0.71
- -1.83
- 4.87
- -2.64
- -1.06
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 994,227 | 1,004,852 | 1,032,135 | 984,168 | 1,002,549 | 1,009,763 | 1,026,117 | 1,011,560 | 1,013,476 | 1,026,623 |
營業成本 | 4,699,671 | -3,349,068 | 675,068 | 666,436 | 4,718,031 | 660,742 | 672,404 | 666,717 | 649,391 | 664,783 |
營業毛利 | -3,705,444 | 4,353,920 | 357,067 | 317,732 | -3,715,482 | 349,021 | 353,713 | 344,843 | 364,085 | 361,840 |
營業費用 | 1,627,128 | -1,204,985 | 256,933 | - | 1,542,017 | - | - | - | 231,163 | 210,338 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 1,290,010 | -916,285 | 191,549 | 177,799 | 1,306,298 | 199,213 | 169,791 | 186,291 | 197,142 | 176,109 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 337,118 | -288,700 | 65,384 | 65,264 | 235,719 | 32,403 | 32,270 | 32,575 | 34,021 | 34,229 |
營業利益 | -283,440 | 133,799 | 100,134 | 74,669 | -167,687 | 117,405 | 151,652 | 125,977 | 132,922 | 151,502 |
其他收入及費用 | 13,116 | -21,196 | 1,251 | -10,807 | -20,870 | 4,120 | 770 | 8,035 | 109,328 | -4,887 |
利息費用 | 190,283 | -141,105 | 29,967 | 27,884 | 224,342 | 30,284 | 32,769 | 35,001 | 33,544 | 33,742 |
稅前純益 | -294,099 | 87,200 | 71,418 | 35,978 | -216,791 | 91,241 | 119,653 | 99,011 | 208,706 | 112,873 |
所得稅 | 103,129 | -89,294 | 18,725 | 10,100 | 138,690 | 20,946 | 25,392 | 24,529 | 19,754 | 24,852 |
稅後純益 | -276,555 | 54,422 | 52,326 | 25,469 | -214,495 | 69,657 | 94,081 | 72,960 | 187,084 | 87,389 |
基本每股稅後盈餘(元) | -5.62 | 1.11 | 1.06 | 0.50 | -4.22 | 1.34 | 1.75 | 1.31 | - | 1.70 |
稀釋每股稅後盈餘(元) | -5.56 | 1.10 | 1.05 | 0.50 | -4.17 | 1.33 | 1.74 | 1.30 | 3.64 | 1.68 |
基本平均股數(千股) | 49216.00 | 49213.00 | 49149.00 | 50677.00 | 51138.00 | 51394.00 | 51551.00 | 51437.00 | - | 51283.00 |
稀釋平均股數(千股) | 49216.00 | 49426.00 | 49316.00 | 50853.00 | 51138.00 | 51583.00 | 51846.00 | 51842.00 | - | 51607.00 |
還原基本每股稅後盈餘(元) | -5.62 | 1.11 | 1.06 | 0.50 | -4.22 | 1.34 | 1.75 | 1.31 | - | 1.70 |
還原稀釋每股稅後盈餘(元) | -5.56 | 1.10 | 1.05 | 0.50 | -4.17 | 1.33 | 1.74 | 1.30 | 3.64 | 1.68 |
還原基本平均股數(千股) | 49,216 | 49,213 | 49,149 | 50,677 | 51,138 | 51,394 | 51,551 | 51,437 | - | 51,283 |
還原稀釋平均股數(千股) | 49,216 | 49,426 | 49,316 | 50,853 | 51,138 | 51,583 | 51,846 | 51,842 | - | 51,607 |
EBITDA(千元) | 95,134 | -90,813 | 220,525 | 183,817 | 250,641 | 209,085 | 238,324 | 217,847 | 320,896 | 224,853 |